| For: | Rafaqat S, Azam A, Hafeez R, Faseeh H, Tariq M, Asif M, Arshad A, Noshair I. Role of interleukins in the pathogenesis of coronary heart disease: A literature review. World J Cardiol 2025; 17(3): 103947 [PMID: 40161563 DOI: 10.4330/wjc.v17.i3.103947] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v17/i3/103947.htm |
| Number | Citing Articles |
| 1 |
Reşat Dikme, İsmail Koyuncu, Mehmet Salih Aydın. Nuclear factor erythroid 2 related factor 2, tumor necrosis factor alpha, interleukin-40, and endorepellin levels in patients undergoing coronary artery bypass grafting. Revista da Associação Médica Brasileira 2026; 72(2) doi: 10.1590/1806-9282.20251054
|
| 2 |
I. F. Shlyk, I. I. Andreeva, M. N. Morgunov, M. V. Kharitonova, D. Yu. Besedina. Cytokine profile of patients with coronary artery calcification without ischemic heart disease.. South Russian Journal of Therapeutic Practice 2025; 6(2) doi: 10.21886/2712-8156-2025-6-2-24-31
|
| 3 |
M. V. Khutornaya, A. V. Sinitskaya, O. N. Khryachkova, A. O. Poddubnyak, M. A. Asanov, A. A. Klyueva, M. Yu. Sinitsky, A. V. Ponasenko, O. L. Barbarash. Polymorphisms of genes related to inflammatory response, endothelial dysfunction, lipid metabolism, and oxidative stress in patients with coronary artery disease. Russian Journal of Cardiology 2025; 30(10) doi: 10.15829/1560-4071-2025-6366
|
| 4 |
Antonis A. Manolis, Theodora A. Manolis, Antonis S. Manolis. Interleukins and Cardiovascular Disease. Cardiology in Review 2026; doi: 10.1097/CRD.0000000000001413
|
| 5 |
M.O. Reviakina, I.A. Snimshchikova. THE ROLE OF NF-ΚB AND PROINFLAMMATORY CYTOKINES IL-1 AND TNF-Α IN THE PATHOGENESIS OF ISCHEMIC HEART DISEASE. Bulletin "Biomedicine and sociology" 2025; 10(4) doi: 10.26787/nydha-2618-8783-2025-10-4-62-70
|
| 6 |
Afsheen Zehra, Hasan Ali, Farzeen Tanwir, Sadia Rehman, Areeb Arif Khan, Anila Bibi. Association of Serum ADMA with Endothelial Dysfunction in Chronic Periodontitis and Coronary Heart Disease Patients. Current Hypertension Reviews 2026; 22(3) doi: 10.2174/0115734021434691260120091010
|
| 7 |
Shicong Xu, Zhihui Zhang, Jing Li, Yiyan Ding, Yuanguo Chen, Yunxia Zhou, Shenglin Hu. Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studies. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02890-7
|
| 8 |
Aneeza Waris Hussain Rathore, Hira Naveed, Atif Nadeem, Aqib Ishaque, Sadia Iqbal, Uswah Ilyas, Tooba Arooj, Saira Rafaqat. Relationship between the oxidative stress biomarkers and coronary heart disease: Pathogenesis to therapeutic aspects. World Journal of Cardiology 2026; 18(2): 113624 doi: 10.4330/wjc.v18.i2.113624
|
| 9 |
Stephanie Wissel, Hubert Scharnagl, Marcus E. Kleber, Graciela Delgado, Angela P. Moissl-Blanke, Bernhard Krämer, Winfried März. Reply to the Letter to the Editor: “Anti-inflammatory role of lipoprotein apheresis in the era of small interfering RNA inhibitor of apolipopritein(a)”. Clinical Research in Cardiology 2025; doi: 10.1007/s00392-025-02807-0
|
| 10 |
Yaning Hu, Yuansheng Liu, Yueping Wang, Fengxu Lin, Ronghong Chen, Chuanjun Chen, Tao Qu. Dual-pathway model of IL-6 and HSP22/HSP27 dynamics predicts post-PCI MACE in STEMI patients. BMC Cardiovascular Disorders 2025; 25(1) doi: 10.1186/s12872-025-05304-4
|
| 11 |
Trilochan Satapathy, Anjali Minj. Bioactive phytochemicals modulating skin depigmentation, inflammation and cardiovascular pathways. Pharmacological Research - Modern Chinese Medicine 2026; 18 doi: 10.1016/j.prmcm.2026.100783
|
| 12 |
M. І. Lutai, O. M. Lomakovsky. Антизапальний ефект аторвастатину в пацієнтів зі стабільною ішемічною хворобою серця. Ukrainian Journal of Cardiology 2025; 32(4) doi: 10.31928/2664-4479-2025.4.1421
|